1 / 33

Benefits of PIC/S Membership for the Philippines

Bob Tribe Former Chairman of PIC/S. Benefits of PIC/S Membership for the Philippines. Overview. Role & functions of PIC/S ( Pharmaceutical Inspection Co-operation Scheme ) PIC/S Members Benefits of PIC/S membership for the Philippines PIC/S Accession Procedure PIC/S GMP Guide

erika
Télécharger la présentation

Benefits of PIC/S Membership for the Philippines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bob Tribe Former Chairman of PIC/S Benefits of PIC/SMembership for the Philippines

  2. Overview • Role & functions of PIC/S (Pharmaceutical Inspection Co-operation Scheme) • PIC/S Members • Benefits of PIC/S membership for the Philippines • PIC/S Accession Procedure • PIC/S GMP Guide • Training for PIC/S Inspectors

  3. PIC/S Goal “To lead the international development, implementation and maintenance of harmonised GMP standards and quality systems of inspectorates in the field of medicinal products”.

  4. Achievement of the Goal PIC/S Goal is achieved by: • Developing and promoting harmonised GMP standards and guidance documents. • Training GMP inspectors of competent authorities. • Assessing (and reassessing) GMP Inspectorates. • Facilitating the co-operation and networking for competent authorities and international organisations.

  5. Main features of PIC/S • Commenced operating in November 1995. • Previously existed as “PIC” (Pharmaceutical Inspection Convention) from Oct 1970 to Nov’95. • Is a “Cooperative Arrangement” between GMP regulatory authorities;ie. not a legal treaty. • A forum for: • networking and confidence building • Exchange of information and experience on GMP • Focus on Quality Systems for Inspectorates • Focus on training of GMP inspectors • International harmonisation of GMP • No obligation for member authorities to accept inspection reports of other members.

  6. Austria Belgium Czech Rep. Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Liechtenst. Lithuania Malta Netherlands Norway Poland Portugal Romania Slovak Rep. Spain Sweden Switzerland UK 37 PIC/S Members(at 1 January 2010) Canada Cyprus Israel Malaysia Singapore Australia Argentina South Africa

  7. How PIC/S Operates • Secretariat (Geneva based) • Executive Bureau (Chairman, two Deputy Chairmen, four Members of PIC/S Committee) • PIC/S Committee (usually the Chief Inspector of each Agency) • Small Budget(members pay annual membership fee) • Good relationships and collaboration(family atmosphere) • Training opportunities(eg. Seminars, Joint visits, coached inspections) • Information exchange(eg. inspection reports, Rapid Alerts) • Development of GMP Guides & guidance documents

  8. Benefits of PIC/S Membership For Regulatory Authorities: • Accession forces improvements – ie. Discipline. • Cost savings – more effective use of resources. • Inspector training (Seminars, Joint Inspections, coached inspections). • Involvement in developing international GMPs. • Promotion of harmonisation of GMP inspections. • Sharing of information & experiences. • Networking & personal contacts.

  9. Benefits of PIC/S Membership For Industry: • Improved consumer protection & confidence. • Reduced duplication of inspections. • Cost savings. • Export facilitation. • Enhanced market access. • Reputation of industry enhanced. • Transparent inspection standards. • Consistency of inspections.

  10. Growth in Australian Exports resulting from PIC/S membership PIC/S Membership Source: The Australian Pharmaceutical Industry and its Global Context, Working Paper No. 7, September 2002. Mr George Messinis, Centre for Strategic Economic Studies, Victoria University of Technology, Melbourne

  11. Benefits of PIC/S Membership For Patients & Consumers: Increased confidence in the quality of medicines supplied in the Philippines. More reliable & consistent quality of medicines. Improved patient & consumer safety & protection. Better control of counterfieted medicines. Improved access to affordable quality medicines.

  12. Applicants currently being assessed for PIC/S membership • Iran • Ukraine • Slovenia • US FDA The GMP Regulatory Authorities of: • Thailand • Indonesia • Philippines

  13. Agencies showing an interest in joining PIC/S • Taiwan • Brazil • Bulgaria • Croatia • PR of China The GMP Regulatory Authorities of: • Japan • Saudi Arabia • South Korea • NZ • Hong Kong

  14. PIC/S Accession Procedure Steps to Accession • General interest & commitment, eg. attend Seminars. • Written application to Secretary + supporting documents (Philippines send application in June 2009). • PIC/S Committee appoints Rapporteur to evaluate. • Applicant invited to Committee meeting to answer questions of Rapporteur and Committee. • PIC/S delegation undertakes assessment visit(assesses Inspectorate’s procedures & Quality System, & observe 3 or 4 inspections). • Delegation report issued (to applicant & Committee). • Committee decides on membership.

  15. PIC/S GMP Guide • PIC/S GMP Guide to GMP for Medicinal Products (PIC/S document PE 009-9, 1 September 2009). • Virtually identical to EC GMP Guide: (main difference = “Qualified Person” vs “authorised person”). • Divided into 3 parts • Part I: PIC/S GMP Guide (general provisions). • Part II: GMP Guide for APIs (identical to ICH Q7A). • Annexes 1 to 20. • (PIC/S GMP Guide available at www.picscheme.org)

  16. PIC/S GMP Guide(PE 009-9, 1 September 2009) • Introduction • Chapter 1 – Quality Management • Chapter 2 – Personnel • Chapter 3 – Premises & Equipment • Chapter 4 – Documentation • Chapter 5 – Production • Chapter 6 – Quality Control • Chapter 7 – Contract Manufacture & Analysis • Chapter 8 – Complaints & Product Recall • Chapter 9 – Self Inspection • (PIC/S GMP Guide available at www.picscheme.org)

  17. PIC/S GMP GuideAnnexes • Sterile Medicinal Products • Biological Products for Human use • Radiopharmaceuticals • Veterinary medicinal products other than immunologicals • Immunological veterinary medicinal products • Medicinal gases • Herbal medicinal products • Sampling of starting and packaging materials • (PIC/S GMP Guide available at www.picscheme.org)

  18. PIC/S GMP GuideAnnexes • Liquids, creams & ointments • Pressurized metered dose aerosol products • Computerised systems • Ionising radiation • Investigational medicinal products • Products derived from human blood or human plasma • Qualification and validation • [Qualified person and batch release] • Parametric release • Reference and retention samples • Quality Risk Management (voluntary)(identical to ICH Q9) • (PIC/S GMP Guide available at www.picscheme.org)

  19. Recent Changes • Changes to the PIC/S GMP Guide since 2006: • “Product Quality Review” (cl. 1.4). • “Quality Risk Management” (cl. 1.5, 1.6; new Annex 20). • “On-going Stability Program” (cl. 6.23 - 6.33). • “Counterfeiting” (cl. 8.7- 8.8). • Significant changes to Annex 1 (Sterile Medicinal Products). • New Annex 19 on “Reference Samples & Retention Samples”. • New Annex 20 on “Quality Risk Management”. Many of these discussed on PharmOut’s “GMP & Validation” Blog at: http://www.pharmout.com.au/blog/

  20. Useful PIC/S Aide Memoires Whilst PIC/S Aide Memoires are written for GMP inspectors, they can be very useful for a company’s internal audits. • Aide Memoire on Inspection of Utilities Sept’07 • Aide Memoire on Inspection of Packaging Jan’09 • Aide Memoire on Inspection of QC Laboratories Sept’07 • Aide Memoire on Inspection of APIs Jan’09 • Aide Memoire on Inspection of Biotech Sept’07 • Aide Memoire on Medicinal Gases Sept’07 • (All available at www.picscheme.org)

  21. Useful PIC/S Guidance Documents • Good Practices for Computerised Systems Sept’07 • Validation (Master Plan, IQ, OQ, Process & Cleaning) Sept’07 • Site Master File Preparation (Explanatory Notes) Sept’07 • Guidance on Parametric Release Sept’07 • Recommendations on Sterility Testing Sept’07 • Isolators for Aseptic Processing and Sterility Testing Sept’07 • Validation of Aseptic Processing June’09 • (All available at www.picscheme.org)

  22. PIC/S Training for GMP Inspectors Training Seminars Joint Visits Groups Coached inspections Expert Circle meetings

  23. Recent PIC/S Training Seminars Biotechnology France, 2000 Inspection of Utilities Czech Rep, 2001 Interface between GCP and GMP Canada, 2002 Inspection of QC laboratories Slovak Rep, 2003 Inspection of APIs Spain, 2004 Packaging/Labelling/Prevention of Mix-ups Romania, 2005 Risk Management Germany, 2006 Inspection of Solid Dosage Forms Singapore, 2007 Inspection of GDP Poland, 2008* Sterile Aseptic Manufacturing Sweden, 2009 *120 participants from 40 different countries (Booklets/CDs of Seminar proceedings available for purchase)

  24. Representatives from Indonesia and Turkey participating in the PIC Seminar on Computer Systems, Sydney, September 1996

  25. Future PIC/S Seminars • Inspection of Traditional Medicines Malaysia, 2010 • Good Inspection Practices South Africa, 2011 (NB: Open to GMP inspectors only, including inspectors from non-PIC/S countries)

  26. PIC/S Joint Visits • Started in 1987. • About 30 groups, with each group comprising 3 inspectors from 3 different countries. • 1 inspection per year per country. • Benefits: • for training purposes • for uniform GMP interpretation • for uniform inspection procedures • for mutual confidence

  27. Coached Inspections • New initiative by PIC/S. • Started in September 2009. • 6 applicants to date – all inexperienced inspectors.

  28. Expert Circle Groups • Human Blood and Tissues • Hospital Pharmacy • Computerized systems • APIs • Quality Risk Management Aim: - Develop draft guidance documents - Training in specialized field

  29. PIC/S Relationship with EMEA • EMEA representative attends PIC/S Committee meetings as an observer • PIC/S-EU liaison officer attends EU Inspectors’ meetings at EMEA as an observer • A harmonised consultation procedure: • EU & PIC/S usually adopt each other’s GMP Guides & guidance documents • An “Associated Partnership” in place

  30. Liaison with other organisations • WHOCo-operation with PQ (Prequalification of Medicines) and IVB (Immunization, Vaccines and Biologicals) • EDQM(The European Department for the Quality of Medicines) – An “Associated Partnership” in place • ICH(participation in the development of ICH Guidelines) • UNICEF- An “Associated Partnership” in place • European Commission (DG SANCO, DG Enterprise)

  31. PIC/S Executive Bureau (2010) • PIC/S Executive Bureau: • Chairman T Gråberg (MPA, Sweden) • 1st Dep. Chairman H Baião (INFARMED, Portugal) • 2nd Dep. Chairman J Gouws (MCC, South Africa) • Member V Revithi (EOF, Greece) • Member P Hargreaves (MHRA, UK) • Member M Boon (HSA, Singapore) • Member J Holy (ISCVBM, Czech Republic)

  32. www.picscheme.org

  33. PIC/S contact details PIC/S Secretariat 14, Rue du Roveray CH - 1207 Geneva Switzerland Tel: +41.22.7389216 Fax: +41.22.7389217 Email: info@picscheme.org Web site:www.picscheme.org

More Related